Glass House Brands (GLASF) Q4 2024 earnings summary

Executive summary

• Achieved significant growth in 2024, including the commercial launch of Greenhouse 5, start of Phase III expansion with Greenhouse 2 retrofit, and targeting over 1M pounds annual capacity.

• Maintained flexibility by pursuing both cannabis and hemp strategies, with initial revenues from Greenhouse 2 expected in Q4 2025 and promising hemp trials in Greenhouse 4.

• Focused on low-cost, high-quality cannabis production, achieving cost reductions and strong brand performance despite challenging California market conditions.

• Strategic product initiatives, including value pricing and brand prioritization, drove growth in all segments despite a 10% decline in taxable California sales.

• Successfully refinanced senior credit facility, improving financial flexibility, lowering interest rate to 8.58%, and extending maturity to 2030.

Financial highlights

• Q4 2024 revenue reached $53 million, up 31% year-over-year, with over 20% growth in all business segments.

• Full-year 2024 revenue was $201 million, a 25% increase year-over-year, driven by a 32% rise in wholesale biomass revenue.

• Sold a record 568,000 lbs of wholesale biomass in 2024, up nearly 70% from 2023, offsetting a 21% drop in average selling price.

• Full-year gross profit hit a record $97 million (48% margin), with gross margin declining only 1% despite price pressures.

• Adjusted EBITDA for 2024 was $40.3 million (20% margin), up 64% year-over-year.

• Ended 2024 with $36.9 million in cash and restricted cash, up $4.4 million year-over-year after CapEx, dividends, and debt payments.

• Q4 net income was $12.2 million, reversing a $38.1 million loss in Q4 2023; full-year net income was $0.7 million.

Outlook and guidance

• Q1 2025 revenue expected at $42–$44 million, over 40% growth year-over-year at midpoint, led by wholesale.

• Q1 2025 production projected at 145,000 lbs (up 136% year-over-year), with cost of production at $130/lb (down 29%).

• Full-year 2025 revenue guidance is $220–$230 million (12% growth at midpoint), with adjusted EBITDA in the mid-$40 million range and positive operating cash flow in the low $40 million range.

• Wholesale biomass production for 2025 expected at 760,000–780,000 lbs, cost of production at $112/lb (down 9%), and average selling price $215–$220/lb.

• Guidance excludes potential upside from hemp operations, Greenhouse 2 expansion, and ERTC receivables.